No CrossRef data available.
Article contents
Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study)
Published online by Cambridge University Press: 25 January 2024
Abstract
Background
The prevalence of medical illnesses is high among patients with psychiatric disorders. The current study aimed to investigate multi-comorbidity in patients with psychiatric disorders in comparison to the general population. Secondary aims were to investigate factors associated with metabolic syndrome and treatment appropriateness of mental disorders.
Methods
The sample included 54,826 subjects (64.73% females; 34.15% males; 1.11% nonbinary gender) from 40 countries (COMET-G study). The analysis was based on the registration of previous history that could serve as a fair approximation for the lifetime prevalence of various medical conditions.
Results
About 24.5% reported a history of somatic and 26.14% of mental disorders. Mental disorders were by far the most prevalent group of medical conditions. Comorbidity of any somatic with any mental disorder was reported by 8.21%. One-third to almost two-thirds of somatic patients were also suffering from a mental disorder depending on the severity and multicomorbidity. Bipolar and psychotic patients and to a lesser extent depressives, manifested an earlier (15–20 years) manifestation of somatic multicomorbidity, severe disability, and probably earlier death. The overwhelming majority of patients with mental disorders were not receiving treatment or were being treated in a way that was not recommended. Antipsychotics and antidepressants were not related to the development of metabolic syndrome.
Conclusions
The finding that one-third to almost two-thirds of somatic patients also suffered from a mental disorder strongly suggests that psychiatry is the field with the most trans-specialty and interdisciplinary value and application points to the importance of teaching psychiatry and mental health in medical schools and also to the need for more technocratically oriented training of psychiatric residents.
- Type
- Original Research
- Information
- Copyright
- © The Author(s), 2024. Published by Cambridge University Press
References
Hoffman, C, Rice, D, Sung, HY. Persons with chronic conditions. Their prevalence and costs. JAMA. 1996;276(18):1473–1479.CrossRefGoogle ScholarPubMed
Neeleman, J, Ormel, J, Bijl, RV. The distribution of psychiatric and somatic III health: associations with personality and socioeconomic status. Psychosom Med. 2001;63(2):239–247. doi:10.1097/00006842-200103000-00007.CrossRefGoogle ScholarPubMed
Parks, J, Svendsen, D, Singer, P, Foti, ME, Mauer, BJA. Morbidity and Mortality in People with Serious Mental Illness. National Association of State Mental Health Program Directors Medical Directors Council; 2006.Google Scholar
Laursen, TM, Munk-Olsen, T, Agerbo, E, Gasse, C, Mortensen, PB. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry. 2009;66(7):713–720. doi:10.1001/archgenpsychiatry.2009.61.CrossRefGoogle ScholarPubMed
Gold, KJ, Kilbourne, AM, MJJofp, V. Primary care of patients with serious mental illness: Your chance to make a difference: A primary care visit may lead to regular care of side effects and comorbidities, especially if you coordinate care. J Fam Pract. 2008;57(8):515–526.Google Scholar
Batki, SL, Meszaros, ZS, Strutynski, K, et al. Medical comorbidity in patients with schizophrenia and alcohol dependence. Schizophr Res. 2009;107(2–3):139–146. doi:10.1016/j.schres.2008.10.016.CrossRefGoogle ScholarPubMed
Correll, CU. Balancing efficacy and safety in treatment with antipsychotics. CNS Spectr. 2007;12(10 Suppl 17):12–20. doi:10.1017/s1092852900026298.CrossRefGoogle ScholarPubMed
Suppes, T, McElroy, SL, Hirschfeld, R. Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder: a survey of 500 US psychiatrists. Psychopharmacol Bull. 2007;40(2):22–37; quiz 38–40.Google ScholarPubMed
Fenton, WS, Chavez, MR. Medication-induced weight gain and dyslipidemia in patients with schizophrenia. Am J Psychiatry. 2006;163(10):1697–1704; quiz 1858–1859. doi:10.1176/ajp.2006.163.10.1697.CrossRefGoogle ScholarPubMed
Parekh, AK, Barton, MB. The challenge of multiple comorbidity for the US health care system. JAMA. 2010;303(13):1303–1304. doi:10.1001/jama.2010.381.CrossRefGoogle ScholarPubMed
Viron, MJ, Stern, TA. The impact of serious mental illness on health and healthcare. Psychosomatics. 2010;51(6):458–465. doi:10.1176/appi.psy.51.6.458.CrossRefGoogle ScholarPubMed
Lawrence, D, Kisely, S, Pais, J. The epidemiology of excess mortality in people with mental illness. Can J Psychiatry. 2010;55(12):752–760. doi:10.1177/070674371005501202.CrossRefGoogle ScholarPubMed
Katon, WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialog Clin Neurosci. 2011;13(1):7–23. doi:10.31887/DCNS.2011.13.1/wkaton.CrossRefGoogle ScholarPubMed
Druss, BG, Walker, ER. Mental disorders and medical comorbidity. Synth Proj Res Synth Rep. 2011;(21):1–26.Google ScholarPubMed
Fountoulakis, KN, Apostolidou, MK, Atsiova, MB, et al. Self-reported changes in anxiety, depression and suicidality during the COVID-19 lockdown in Greece. J Affect Disord. 2021;279:624–629. doi:10.1016/j.jad.2020.10.061.CrossRefGoogle ScholarPubMed
Fountoulakis, KN, Apostolidou, MK, Atsiova, MB, et al. Mental health and conspiracism in health care professionals during the spring 2020 COVID-19 lockdown in Greece. Acta Neuropsychiatr. 2022;34(3):132–147. doi:10.1017/neu.2021.38.CrossRefGoogle Scholar
Fountoulakis, KN, Karakatsoulis, G, Abraham, S, et al. Results of the COVID-19 mental health international for the general population (COMET-G) study. Eur Neuropsychopharmacol. 2022;54:21–40. doi:10.1016/j.euroneuro.2021.10.004CrossRefGoogle ScholarPubMed
Fountoulakis, KN, Karakatsoulis, GN, Abraham, S, et al. The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study. Psychiatry Res. 2022;315:114702. doi:10.1016/j.psychres.2022.114702.CrossRefGoogle ScholarPubMed
K, NF, G, NK, Abraham, S, et al. Results of the COVID-19 Mental Health International for the Health Professionals (COMET-HP) study: depression, suicidal tendencies and conspiracism. Soc Psychiatry Psychiatr Epidemiol. 2023;58:1–24. doi:10.1007/s00127-023-02438-8.Google Scholar
Patsali, ME, Mousa, DV, Papadopoulou, EVK, et al. University students’ changes in mental health status and determinants of behavior during the COVID-19 lockdown in Greece. Psychiatry Res. 2020;292:113298. doi:10.1016/j.psychres.2020.113298.CrossRefGoogle ScholarPubMed
Bourdon, KH, Rae, DS, Locke, BZ, Narrow, WE, Regier, DA. Estimating the prevalence of mental disorders in U.S. adults from the Epidemiologic Catchment Area Survey. Public Health Rep. 1992;107(6):663–668.Google ScholarPubMed
Wittchen, HU, Jacobi, F. Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15(4):357–376. doi:10.1016/j.euroneuro.2005.04.012.CrossRefGoogle ScholarPubMed
Goodwin, RD, Dierker, LC, Wu, M, Galea, S, Hoven, CW, Weinberger, AH. Trends in U.S. depression prevalence from 2015 to 2020: the widening treatment gap. Am J Prev Medi. 2022;63(5):726–733. doi:10.1016/j.amepre.2022.05.014.CrossRefGoogle ScholarPubMed
Lim, GY, Tam, WW, Lu, Y, Ho, CS, Zhang, MW, Ho, RC. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. 2018;8(1):2861. doi:10.1038/s41598-018-21243-x.CrossRefGoogle ScholarPubMed
Bebbington, P, Ramana, R. The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol. 1995;30(6):279–292. doi:10.1007/BF00805795.CrossRefGoogle ScholarPubMed
Pini, S, de Queiroz, V, Pagnin, D, et al. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol. 2005;15(4):425–434. doi:10.1016/j.euroneuro.2005.04.011.CrossRefGoogle ScholarPubMed
Merikangas, KR, Jin, R, He, JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241–251. doi:10.1001/archgenpsychiatry.2011.12.CrossRefGoogle ScholarPubMed
Fountoulakis, KN. Classification and Epidemiology. In: Fountoulakis, KN, ed. Bipolar Disorder. Berlin, Heidelberg: Springer; 2015:341–360; Chapter 11.CrossRefGoogle ScholarPubMed
Eaton, WW. Update on the epidemiology of schizophrenia. Epidemiol Rev. 1991;13:320–328. doi:10.1093/oxfordjournals.epirev.a036075.CrossRefGoogle ScholarPubMed
McGrath, J, Saha, S, Chant, D, Welham, J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67–76. doi:10.1093/epirev/mxn001.CrossRefGoogle ScholarPubMed
Agley, J, Xiao, Y. Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science. BMC Public Health. 2021;21(1):89. doi:10.1186/s12889-020-10103-x.CrossRefGoogle Scholar
Cipriano, A, Cella, S, Cotrufo, P. Nonsuicidal self-injury: a systematic review. Front Psychol. 2017;8:1946. doi:10.3389/fpsyg.2017.01946.CrossRefGoogle ScholarPubMed
Lucena, NL, Rossi, TA, Azevedo, LMG, Pereira, M. Self-injury prevalence in adolescents: a global systematic review and meta-analysis. Child Youth Serv Rev. 2022;142:106634. doi:10.1016/j.childyouth.2022.106634.CrossRefGoogle Scholar
Fountoulakis, KN, Grammatikopoulos, IA, Koupidis, SA, Siamouli, M, Theodorakis, PN. Health and the financial crisis in Greece. Lancet. 2012;379(9820):1001–1002. doi:10.1016/S0140-6736(12)60422-X.CrossRefGoogle ScholarPubMed
Fairweather-Schmidt, AK, Anstey, KJ. Prevalence of suicidal behaviours in two Australian general population surveys: methodological considerations when comparing across studies. Soc Psychiatry Psychiatr Epidemiol. 2012;47(4):515–522. doi:10.1007/s00127-011-0369-5.CrossRefGoogle ScholarPubMed
Borges, G, Nock, MK, Haro Abad, JM, et al. Twelve-month prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys. J Clin Psychiatry. 2010;71(12):1617–1628. doi:10.4088/JCP.08m04967blu.CrossRefGoogle ScholarPubMed
Borges, G, Angst, J, Nock, MK, Ruscio, AM, Walters, EE, Kessler, RC. A risk index for 12-month suicide attempts in the National Comorbidity Survey Replication (NCS-R). Psychol Med. 2006;36(12):1747–1757. doi:10.1017/S0033291706008786.CrossRefGoogle ScholarPubMed
Kessler, RC, Borges, G, Walters, EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999;56(7):617–626. doi:10.1001/archpsyc.56.7.617CrossRefGoogle ScholarPubMed
Nock, MK, Borges, G, Bromet, EJ, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008;192(2):98–105. doi:10.1192/bjp.bp.107.040113.CrossRefGoogle ScholarPubMed
Schmidtke, A, Bille-Brahe, U, De Leo, D, et al. Attempted suicide in Europe: rates, trends and sociodemographic characteristics of suicide attempters during the period 1989–1992. Results of the WHO/EURO Multicentre Study on Parasuicide. Acta Psychiatr Scand. 1996;93(5):327–338. doi:10.1111/j.1600-0447.1996.tb10656.x.CrossRefGoogle ScholarPubMed
Liu, X, Huang, Y, Liu, Y. Prevalence, distribution, and associated factors of suicide attempts in young adolescents: School-based data from 40 low-income and middle-income countries. PLoS One. 2018;13 (12):e0207823 doi:10.1371/journal.pone.0207823.CrossRefGoogle ScholarPubMed
Van Meter, AR, Knowles, EA, Mintz, EH. Systematic review and meta-analysis: international prevalence of suicidal ideation and attempt in youth. J Am Acad Child Adolesc Psychiatry. 2022;62:973–986. doi:10.1016/j.jaac.2022.07.867.CrossRefGoogle ScholarPubMed
Amiri, P, Kazeminasab, S, Nejadghaderi, SA, et al. Migraine: a review on its history, global epidemiology, risk factors, and comorbidities. Front Neurol. 2021;12:800605 doi:10.3389/fneur.2021.800605.CrossRefGoogle Scholar
Fiest, KM, Sauro, KM, Wiebe, S, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017;88(3):296–303. doi:10.1212/WNL.0000000000003509.CrossRefGoogle ScholarPubMed
Singh, P, Arora, A, Strand, TA, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823–836.e2. doi:10.1016/j.cgh.2017.06.037.CrossRefGoogle ScholarPubMed
Bobo, WV, Yawn, BP, Sauver, JL, Grossardt, BR, Boyd, CM, Rocca, WA. Prevalence of combined somatic and mental health multimorbidity: patterns by age, sex, and race/ethnicity. J Gerontol A. 2016;71(11):1483–1491. doi:10.1093/gerona/glw032.CrossRefGoogle ScholarPubMed
Wu, LT, Zhu, H, Ghitza, UE. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data. Drug Alcohol Depend. 2018;192:316–323. doi:10.1016/j.drugalcdep.2018.08.013.CrossRefGoogle ScholarPubMed
Nolte, H, Nepper-Christensen, S, Backer, V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med. 2006;100(2):354–362. doi:10.1016/j.rmed.2005.05.012.CrossRefGoogle ScholarPubMed
de Marco, R, Cerveri, I, Bugiani, M, Ferrari, M, Verlato, G. An undetected burden of asthma in Italy: the relationship between clinical and epidemiological diagnosis of asthma. Eur Respir J. 1998;11(3):599–605.CrossRefGoogle ScholarPubMed
Collins, PY, Patel, V, Joestl, SS, et al. Grand challenges in global mental health. Nature. 2011;475(7354):27–30. doi:10.1038/475027a.CrossRefGoogle ScholarPubMed
Benyamina, A, Blecha, L, Reynaud, M. Global burden of disease in young people aged 10–24 years. Lancet. 2012;379(9810):29. doi:10.1016/S0140-6736(12)60021-X.CrossRefGoogle ScholarPubMed
Harhay, MO, King, CH. Global burden of disease in young people aged 10–24 years. Lancet. 2012;379(9810):27–28. doi:10.1016/S0140-6736(12)60019-1.CrossRefGoogle ScholarPubMed
Gore, FM, Bloem, PJ, Patton, GC, et al. Global burden of disease in young people aged 10–24 years: a systematic analysis. Lancet. 2011;377(9783):2093–2102. doi:10.1016/S0140-6736(11)60512-6.CrossRefGoogle ScholarPubMed
Bertolote, JM, Fleischmann, A. Suicide and psychiatric diagnosis: a worldwide perspective. World Psychiatry. 2002;1(3):181–185.Google ScholarPubMed
Ronaldson, A, Arias de la Torre, J, Prina, M, et al. Associations between physical multimorbidity patterns and common mental health disorders in middle-aged adults: A prospective analysis using data from the UK Biobank. Lancet Reg Health Eur. 2021;8:100149. doi:10.1016/j.lanepe.2021.100149.CrossRefGoogle ScholarPubMed
Yao, SS, Cao, GY, Han, L, et al. Associations between somatic multimorbidity patterns and depression in a longitudinal cohort of middle-aged and older Chinese. J Am Med Dir Assoc. 2020;21(9):1282–1287.e2. doi:10.1016/j.jamda.2019.11.028.CrossRefGoogle Scholar
Li, H, Wang, A, Gao, Q, et al. Prevalence of somatic-mental multimorbidity and its prospective association with disability among older adults in China. Aging (Albany NY). 2020;12(8):7218–7231. doi:10.18632/aging.103070.CrossRefGoogle ScholarPubMed
Galenkamp, H, Braam, AW, Huisman, M, Deeg, DJ. Somatic multimorbidity and self-rated health in the older population. J Gerontol B Psychol Sci Soc Sci. 2011;66(3):380–386. doi:10.1093/geronb/gbr032.CrossRefGoogle ScholarPubMed
de Mooij, LD, Kikkert, M, Theunissen, J, et al. Dying too soon: excess mortality in severe mental illness. Front Psychiatry. 2019;10:855. doi:10.3389/fpsyt.2019.00855.CrossRefGoogle ScholarPubMed
Walker, ER, McGee, RE, Druss, BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334–341. doi:10.1001/jamapsychiatry.2014.2502.CrossRefGoogle ScholarPubMed
Chesney, E, Goodwin, GM, Fazel, S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153–160. doi:10.1002/wps.20128.CrossRefGoogle ScholarPubMed
Weye, N, Momen, NC, Christensen, MK, et al. Association of specific mental disorders with premature mortality in the danish population using alternative measurement methods. JAMA Netw Open. 2020;3(6):e206646. doi:10.1001/jamanetworkopen.2020.6646.CrossRefGoogle ScholarPubMed
Colton, CW, Manderscheid, RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.Google ScholarPubMed
Dembling, BP, Chen, DT, Vachon, L. Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr Serv. 1999;50(8):1036–1042. doi:10.1176/ps.50.8.1036.CrossRefGoogle Scholar
Tiihonen, J, Lonnqvist, J, Wahlbeck, K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620–627. doi:10.1016/S0140-6736(09)60742-X.CrossRefGoogle ScholarPubMed
Harris, EC, Barraclough, B. Excess mortality of mental disorder. Br J Psychiatry. 1998;173(1):11–53. doi:10.1192/bjp.173.1.11.CrossRefGoogle ScholarPubMed
Fond, G, Tinland, A, Boucekine, M, et al. Prescription of potentially inappropriate psychotropic drugs in homeless people with schizophrenia and bipolar disorders. Results from the French Housing First (FHF) program. Prog Neuropsychopharmacol Biol Psychiatry. 2019;89:84–89. doi:10.1016/j.pnpbp.2018.08.024.CrossRefGoogle ScholarPubMed
Gramaglia, E, Ramella Gigliardi, V, Olivetti, I, et al. Impact of short-term treatment with benzodiazepines and imidazopyridines on glucose metabolism in healthy subjects. J Endocrinol Invest. 2014;37(2):203–206. doi:10.1007/s40618-013-0016-y.CrossRefGoogle ScholarPubMed
Gu, XH, Kurose, T, Kato, S, et al. Suppressive effect of GABA on insulin secretion from the pancreatic beta-cells in the rat. Life Sci. 1993;52(8):687–694. doi:10.1016/0024-3205(93)90229-v.CrossRefGoogle ScholarPubMed
Passariello, N, Giugliano, D, Torella, R, Sgambato, S, Coppola, L, Frascolla, N. A possible role of gamma-aminobutyric acid in the control of the endocrine pancreas. J Clin Endocrinol Metab. 1982;54(6):1145–1149. doi:10.1210/jcem-54-6-1145.CrossRefGoogle ScholarPubMed
Chevassus, H, Mourand, I, Molinier, N, Lacarelle, B, Brun, JF, Petit, P. Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124]. BMC Clin Pharmacol. 2004;4:3. doi:10.1186/1472-6904-4-3.CrossRefGoogle ScholarPubMed